Figure 3. Neurofilament Light Protein in Participants With Autopsy-Verified Neurodegenerative Diseases.
Neurofilament light levels in clinically diagnosed control participants are added as a dotted line for reference. The graph omits outlier data points (neurofilament light levels >5000 pg/mL) for 1 participant with frontotemporal lobe degeneration and 2 with amyotrophic lateral sclerosis.